![[Figure 1]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003700/image_t/tCD003700-AFig-FIG11.png?v=1&t=h2rhyc46&s=5c2e26682b58b4f8aafeef5a4e9c2924f90542cb) | Figure 1. Search strategy in the Chinese databases. |
![[Figure 2]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003700/image_t/tCD003700-AFig-FIG01.png?v=1&t=h2rhyc48&s=949a4bff6742c04082d8f536c48843896de12d34) | Figure 2. Methodological quality graph: review authors' judgements about each methodological quality item presented as percentages across all included studies. |
![[Figure 3]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003700/image_t/tCD003700-AFig-FIG02.png?v=1&t=h2rhyc4b&s=6e5237e260dbb1874dee304873d6738017f37318) | Figure 3. Methodological quality summary: review authors' judgements about each methodological quality item for each included study. |
![[Figure 4]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003700/image_t/tCD003700-AFig-FIG03.png?v=1&t=h2rhyc4e&s=0164df7bf13c564242979e4fe649cc956b4b3dc4) | Figure 4. Forest plot of comparison: 1 Vitamin A versus control, outcome: 1.1 Mortality during hospitalisation. |
![[Figure 5]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003700/image_t/tCD003700-AFig-FIG04.png?v=1&t=h2rhyc4g&s=1d3cf32ea1e49b058a4d5e2b98084295cfcc8add) | Figure 5. Forest plot of comparison: 1 Vitamin A versus control, outcome: 1.2 Time with signs of pneumonia and treatment issues (continuous). |
![[Figure 6]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003700/image_t/tCD003700-AFig-FIG05.png?v=1&t=h2rhyc4i&s=77fa48f6bbbdd70c0d1e5c7c6c3c92abde73edd3) | Figure 6. Forest plot of comparison: 1 Vitamin A versus control, outcome: 1.3 Time with signs of pneumonia and treatment issues (dichotomous). |
![[Figure 7]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003700/image_t/tCD003700-AFig-FIG07.png?v=1&t=h2rhyc4l&s=1a4c75dc47595918a4939079559f91d70e32a543) | Figure 7. Forest plot of comparison: 1 Vitamin A versus control, outcome: 1.5 Time with fever, tachypnoea and hypoxaemia of pneumonia (serum retinol > 200 ug/L). |
![[Figure 8]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003700/image_t/tCD003700-AFig-FIG06.png?v=1&t=h2rhyc59&s=c431d1bd0b6b09a13a683904ac5b55fefc8746e8) | Figure 8. Forest plot of comparison: 1 Vitamin A versus control, outcome: 1.4 Adverse events. |
![[Figure 9]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003700/image_t/tCD003700-AFig-FIG08.png?v=1&t=h2rhyc5b&s=5a4387cfa867dca8f108c8e9430ad99c776ede41) | Figure 9. Primary outcomes |
![[Figure 10]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003700/image_t/tCD003700-AFig-FIG09.png?v=1&t=h2rhyc5e&s=807ddbb3fc467653cf2217620b55033c6c6f6ab0) | Figure 10. Secondary outcomes |
![[Figure 11]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003700/image_t/tCD003700-AFig-FIG10.png?v=1&t=h2rhyc5g&s=018d896c07710812a3dea7782032aef94ce8856a) | Figure 11. Adverse events and secondary outcome |
![[Analysis 1.1]](/images/14651858/forrest_default.gif) | Analysis 1.1. Comparison 1 Vitamin A versus control, Outcome 1 Mortality during hospitalisation. |
![[Analysis 1.2]](/images/14651858/forrest_default.gif) | Analysis 1.2. Comparison 1 Vitamin A versus control, Outcome 2 Time with signs of pneumonia and treatment issues (continuous). |
![[Analysis 1.3]](/images/14651858/forrest_default.gif) | Analysis 1.3. Comparison 1 Vitamin A versus control, Outcome 3 Time with signs of pneumonia and treatment issues (dichotomous). |
![[Analysis 1.4]](/images/14651858/forrest_default.gif) | Analysis 1.4. Comparison 1 Vitamin A versus control, Outcome 4 Adverse events. |
![[Analysis 1.5]](/images/14651858/forrest_default.gif) | Analysis 1.5. Comparison 1 Vitamin A versus control, Outcome 5 Time with fever, tachypnoea and hypoxaemia of pneumonia (serum retinol > 200 ug/L). |